
A plan to give people in the United States easier access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. was opposed by most Food and Drug Administration scientific staff members, who had limited input in drafting the policy, according to six people familiar with its development.
Topics: food and drug administration | peptides | Robert F. Kennedy Jr | U.S. Department of Health and Human Services
By: Matthew Perrone, Associated Press
Posted: 2026-10-28 21:20:55














